MCF-7; a human breast cancer cell line with estrogen, androgen, progesterone, and glucocorticoid receptors.
about
Activity and expression of progesterone metabolizing 5alpha-reductase, 20alpha-hydroxysteroid oxidoreductase and 3alpha(beta)-hydroxysteroid oxidoreductases in tumorigenic (MCF-7, MDA-MB-231, T-47D) and nontumorigenic (MCF-10A) human breast cancer cVersican G3 domain modulates breast cancer cell apoptosis: a mechanism for breast cancer cell response to chemotherapy and EGFR therapyInfluence of the estrous cycle on clock gene expression in reproductive tissues: effects of fluctuating ovarian steroid hormone levelsNovel biomarkers for prostate cancer including noncoding transcripts.Increasing the antigenicity of synthetic tumor-associated carbohydrate antigens by targeting Toll-like receptorsTransient expression of the chicken lysozyme gene after transfer into human cells.The upstream regulatory region of the human papilloma virus-16 contains an E2 protein-independent enhancer which is specific for cervical carcinoma cells and regulated by glucocorticoid hormones.In vivo and in vitro estrogenic and progestagenic actions of Tibolone.Transcription factor Ets1 cooperates with estrogen receptor α to stimulate estradiol-dependent growth in breast cancer cells and tumors.Tissue interaction in androgen response of embryonic mammary rudiment of mouse: identification of target tissue for testosteroneMCF-7 Human Breast Cancer Cells Form Differentiated Microtissues in Scaffold-Free Hydrogels.The naphthol selective estrogen receptor modulator (SERM), LY2066948, is oxidized to an o-quinone analogous to the naphthol equine estrogen, equilenin.Estrogen-induced hyperplasia and neoplasia in the rat anterior pituitary gland. An immunohistochemical study.Oestrogenic and antioestrogenic actions in a series of triphenylbut-1-enes: modulation of prolactin synthesis in vitro.Differential regulation by estrogens of growth and prolactin synthesis in pituitary cells suggests that only a small pool of estrogen receptors is required for growth.Immunofluorescent detection of hormone receptors in cutaneous melanocytic tumours.Growth and histology of a human mammary-carcinoma cell line at different sites in the athymic mouseDoes progesterone receptor in human breast cancer reflect the mast-cell content of the tumour tissue?Progesterone receptor subunits are high-affinity substrates for phosphorylation by epidermal growth factor receptor.Endocrine disruptors fludioxonil and fenhexamid stimulate miR-21 expression in breast cancer cells.Identification of an estrogen-responsive element from the 5'-flanking region of the rat prolactin geneEffect of the extracellular matrix on plasminogen activator isozyme activities of human mammary epithelial cells in cultureChemical modification modulates estrogenic activity, oxidative reactivity, and metabolic stability in 4'F-DMA, a new benzothiophene selective estrogen receptor modulator.Minireview: nuclear receptors and breast cancerCanine vascular tissues are targets for androgens, estrogens, progestins, and glucocorticoids.Regulation of cytoplasmic dihydrotestosterone binding in dog prostate by 17 beta-estradiol.Estrogen-induced transcription of the progesterone receptor gene does not parallel estrogen receptor occupancy.Relationship of progesterone- and estradiol-binding proteins in Coccidioides immitis to coccidioidal dissemination in pregnancy.Biochemical assessment of histochemical methods for oestrogen receptor localisationThe membrane actions of estrogens can potentiate their lordosis behavior-facilitating genomic actions.Estrogen control of prolactin synthesis in vitroOrbital metastasis: clinical features, management and outcome.Glucocorticoid receptor and breast cancer.MCF-7 cells--changing the course of breast cancer research and care for 45 years.Steroid hormone receptors as prognostic markers in breast cancer.Estrogen receptor reduces CYP1A1 induction in cultured human endometrial cells.Development of 2,3,5-triaryl-1H-pyrroles as estrogen receptor α selective ligands.A role for progesterone in breast cancer.GR and ER Coactivation Alters the Expression of Differentiation Genes and Associates with Improved ER+ Breast Cancer Outcome.Progesterone and glucocorticoid interactions with receptor in breast cancer cells in long-term tissue culture.
P2860
Q24794475-E923495F-6D7C-4D12-B1D6-5871B93F0158Q28477876-608B5B5C-9624-4434-A38A-0663A0820F05Q30433104-2880C41E-7666-47FC-8AE5-2F2A997A2C69Q33515231-92BE0F4A-4654-4093-A815-6FC9E6C392D1Q33591916-ED0E2A71-4C35-4A84-B355-1B4CEA50C0AEQ33928180-29E55318-BC8A-467D-B553-CC2390417F55Q33929973-1DB34D7F-B054-478C-9FF0-6286B139B762Q34293626-F78CB1A8-BBBC-4A7F-B57B-E90093FEFEA1Q34851281-B4CCA234-D555-4E68-B5CD-DCDCED715300Q35035898-2AB7DBF7-39A8-4DFB-A289-08E5FA843B46Q35744004-37148365-506E-4A70-BFCA-DE2C7CCDD17DQ35869879-0563FAD4-B3E1-42B5-A550-5E659EBEBC76Q35885958-9675781F-AB30-478B-8838-0E15B59BCE53Q35887075-26D41206-4733-43D1-824F-CE898B58BF9AQ35914377-836C6E20-999B-4175-9563-120D4952223DQ36045237-FDE883FF-60FD-42F5-B352-BC48E3F63246Q36046076-473E4B7A-1D2B-4D97-AEBB-FA6C8D20EF69Q36046345-741515FD-6E45-4C7B-ADCD-F269AA7B21C0Q36255158-F2CC25E4-59DA-4084-969A-5E3DD26F00F8Q36509058-8F7607EC-E2D1-4EF2-AE98-069B03D8B4D2Q36924882-C8DE0F9D-1A3D-4F48-A741-B7BF5A018C51Q36939479-8893AD06-85D9-4857-B324-27EAA6495757Q36943022-8ED704E1-1AB0-433B-B5BF-6A76EE073389Q36971797-CCDA0244-BF85-411D-8ACB-557AE1526D52Q36982024-30CF0607-4EB3-4F19-8EA5-EE9881D518A3Q37036148-A8A73483-5583-4C0E-A26B-AA6DA3DFACC0Q37088121-AF461F18-47D9-484B-9D76-72ADAE3D1BD9Q37111507-2912DFFC-3CA1-4A8C-94FC-89440D3F7F05Q37158152-EA5AD492-F332-45E7-BA0D-4C994DD6268FQ37485100-FB46F182-7A06-4930-ADEA-9FE5BF7B56EFQ37596085-A63CCAEA-3CFB-484F-B620-0B0DF599D6C4Q37617411-989F07BA-5C76-4491-8421-A3C2BD5938CEQ37912048-7DE0ECCE-4F8E-47FC-8E1C-2071EE54E66EQ38398503-7450B8ED-0182-41F0-AA67-CB1691659393Q38598704-791A2F27-09CF-42A0-8025-D29D74375AD2Q39396604-1C2A73E9-4C60-4401-A59F-0B9AEFE8D51CQ39459674-D93AD92B-547B-4A73-A954-C7F82C5E0B4EQ39779587-F9B55DC6-5A30-4610-87B7-8242C1E895CEQ39798790-D7EB9365-0683-4C2B-838F-E15C595317A7Q40565729-DAC6A7BC-7848-417B-AEE5-DDA3CA09E946
P2860
MCF-7; a human breast cancer cell line with estrogen, androgen, progesterone, and glucocorticoid receptors.
description
1975 nî lūn-bûn
@nan
1975年の論文
@ja
1975年学术文章
@wuu
1975年学术文章
@zh-cn
1975年学术文章
@zh-hans
1975年学术文章
@zh-my
1975年学术文章
@zh-sg
1975年學術文章
@yue
1975年學術文章
@zh
1975年學術文章
@zh-hant
name
MCF-7; a human breast cancer c ...... and glucocorticoid receptors.
@en
MCF-7; a human breast cancer c ...... and glucocorticoid receptors.
@nl
type
label
MCF-7; a human breast cancer c ...... and glucocorticoid receptors.
@en
MCF-7; a human breast cancer c ...... and glucocorticoid receptors.
@nl
prefLabel
MCF-7; a human breast cancer c ...... and glucocorticoid receptors.
@en
MCF-7; a human breast cancer c ...... and glucocorticoid receptors.
@nl
P2093
P1433
P1476
MCF-7; a human breast cancer c ...... and glucocorticoid receptors.
@en
P2093
Costlow ME
Horwitz KB
McGuire WL
P304
P356
10.1016/0039-128X(75)90110-5
P577
1975-12-01T00:00:00Z